Lexington, Mass. –- Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the appointment of Kevin Hrusovsky as Executive Chairman of its Board of Directors. Hrusovsky brings over twenty years of experience in life science and diagnostics industries with a strong track record […]
SAN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading health insurance company covering 13 million people throughout the United States, to provide the MaterniT21™ PLUS laboratory-developed test (LDT). The addition […]
Singapore — BD has announced through its Singapore-based subsidiary, Becton Dickinson Holdings Pte Ltd, the signing of a distribution agreement with AITbiotech Pte Ltd, a leading manufacturer of molecular diagnostic (MDx) assays and provider of genomic services based in Singapore, for the distribution of AITbiotechabTES™ BM qPCR assays in the Asia Pacific region. “Our agreement […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) is pleased to announce that the Cerilliant® brand within its Applied Diagnostics and Testing business segment has introduced six new certified Snap-N-Spike® reference standards of designer psychedelics in the NBOMe (N-methoxybenzyl-substituted) class of phenethylamines. New products include 25I-NBOMe HCl, 25C-NBOMe HCl, and 25B-NBOMe HCl and their deuterium labeled […]
MILFORD, Mass. — Waters® Corporation (NYSE: WAT) today announced that the Chinese Food and Drug Administration (CFDA) approved the registration of the ACQUITY UPLC® TQD system for legal promotion and sale in China as a medical device for routine diagnostic applications and neonatal metabolites diseases screening. A continuation of Waters’ commitment to China and to […]
Cambridge, MA — Global bioinformatics software company Omixon, headquartered in Budapest with US offices in Cambridge, MA, announces an exclusive licensing agreement with The Children’s Hospital of Philadelphia (CHOP) to commercialize a new Next Generation Sequencing (NGS) HLA genotyping assay, for use on the Illumina® MiSeq sequencing platform. The Illumina-specific HLA genotyping protocol was developed […]
WALTHAM, Mass.– PerkinElmer, Inc., (NYSE: PKI), a global leader focused on the health and safety of people and the environment, today announced an agreement to serve as the exclusive collaborator with China’s National Health and Family Planning Commission (NHFPC) in developing and implementing an extensive three-year newborn screening training program focused on early detection of […]
Durham, NC — bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the appointment of Stefan Willemsen as President and CEO of bioMérieux Inc. He will lead all administrative, commercial and production operations of the bioMérieux Group in the recently created North and Latin America region. Mr. Willemsen will […]
SEATTLE –– NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a collaboration with Celgene Corporation to develop a companion diagnostic assay using the nCounter® Analysis System to support the clinical validation of REVLIMID® for treatment of Diffuse Large B-Cell […]
Basel — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Genia Technologies, Inc. (Genia), a privately held company, based in Mountain View, California, USA. Genia is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore technology. Under the terms of the agreement, Roche will pay Genia’s shareholders USD 125 million in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
